1 |
Abbott Laboratories et al v. Watson Laboratories, Inc.-Florida et al |
0:10-cv-60677 |
S.D.Fla. |
|
|
|
|
2 |
Abbott Laboratories et al v. Watson Laboratories, Inc.-Florida et al |
0:10-cv-60677 |
S.D.Fla. |
|
|
|
|
3 |
Alcon Pharmaceuticals Ltd et al v. Watson Laboratories Inc. et al |
1:11-cv-00293 |
D.Del. |
|
|
|
|
4 |
Alcon Pharmaceuticals Ltd et al v. Watson Laboratories Inc. et al |
1:11-cv-00293 |
D.Del. |
|
|
|
|
5 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
6 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
7 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
8 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
9 |
AUXILIUM PHARMACEUTICALS, INC. et al v. WATSON LABORATORIES, INC. (NV) et al |
2:12-cv-03084 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
10 |
AUXILIUM PHARMACEUTICALS, INC. et al v. WATSON LABORATORIES, INC. (NV) et al |
2:12-cv-03084 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
11 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
12 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
13 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
14 |
Avanir Pharmaceuticals Inc. v. Watson Pharmaceuticals Inc. et al |
1:12-cv-01124 |
D.Del. |
|
|
|
|
15 |
Biovail Laboratories International SRL v. Watson Pharmaceuticals, Inc. et al |
1:10-cv-21241 |
S.D.Fla. |
|
|
|
|
16 |
Bristol-Myers v. Danbury Pharmacal, et al |
3:01-cv-00304 |
D.Conn. |
|
|
|
|
17 |
CELGENE CORPORATION v. NATCO PHARMA LIMITED et al |
2:12-cv-04571 |
D.N.J. |
|
|
|
|
18 |
CELGENE CORPORATION v. NATCO PHARMA LIMITED et al |
2:14-cv-03126 |
D.N.J. |
|
|
|
|
19 |
Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:08-cv-00330 |
D.Del. |
|
|
|
|
20 |
Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:08-cv-00330 |
D.Del. |
|
|
|
|
21 |
Daiichi Sankyo Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:11-cv-00074 |
D.Del. |
|
|
|
|
22 |
Daiichi Sankyo Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:11-cv-00074 |
D.Del. |
|
|
|
|
23 |
Depomed Inc. et al v. Watson Laboratories Inc. Florida et al |
1:12-cv-00492 |
D.Del. |
|
|
|
|
24 |
Depomed Inc. et al v. Watson Laboratories Inc. Florida et al |
1:12-cv-00492 |
D.Del. |
|
|
|
|
25 |
Depomed Inc. et al v. Watson Laboratories Inc. Florida et al |
1:12-cv-00492 |
D.Del. |
|
|
|
|
26 |
Depomed Inc. v. Watson Laboratories Inc. - Florida et al |
1:13-cv-00342 |
D.Del. |
|
|
|
|
27 |
DEPOMED, INC. v. ACTAVIS ELIZABETH LLC et al |
3:12-cv-01358 |
D.N.J. |
|
|
|
|
28 |
Dey v. Watson Pharmaceuticals Inc |
5:06-cv-00395 |
C.D.Cal. |
|
|
|
|
29 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. ACTAVIS, INC. et al |
2:14-cv-02661 |
D.N.J. |
|
|
|
|
30 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. ACTAVIS, INC. et al |
2:14-cv-02661 |
D.N.J. |
|
|
|
|
31 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
32 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
33 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
34 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
35 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
36 |
Merck & Cie et al v. Watson Laboratories Inc. |
1:12-cv-00161 |
D.Del. |
|
|
|
|
37 |
Merck & Cie et al v. Watson Laboratories Inc. |
1:12-cv-00161 |
D.Del. |
|
|
|
|
38 |
Merck & Cie et al v. Watson Laboratories Inc. |
1:12-cv-00161 |
D.Del. |
|
|
|
|
39 |
Momenta Pharmaceuticals, Inc. et al v. Amphastar Pharmaceuticals, Inc. et al |
1:11-cv-11681 |
D.Mass. |
|
|
|
|
40 |
Momenta Pharmaceuticals, Inc. et al v. Amphastar Pharmaceuticals, Inc. et al |
1:11-cv-11681 |
D.Mass. |
|
|
|
|
41 |
Pfizer Inc. et al v. Watson Pharmaceuticals, Inc. et al |
1:04-cv-05212 |
S.D.N.Y. |
|
|
|
|
42 |
Pfizer Inc. et al v. Watson Pharmaceuticals, Inc. et al |
1:04-cv-05212 |
S.D.N.Y. |
|
|
|
|
43 |
Pfizer Inc. et al v. Watson Pharmaceuticals, Inc. et al |
1:04-cv-05212 |
S.D.N.Y. |
|
|
|
|
44 |
PFIZER INC. v. WATSON PHARMACEUTICALS, INC. |
2:04-cv-04789 |
D.N.J. |
|
|
|
|
45 |
Platt v. Bayer Corporation, et al |
2:01-cv-02155 |
W.D.Tenn. |
|
|
|
|
46 |
PURDUE PHARMACEUTICAL PRODUCTS, L.P. et al |
2:12-cv-05390 |
D.N.J. |
|
|
|
|
47 |
PURDUE PHARMACEUTICAL PRODUCTS, L.P. et al |
2:12-cv-05390 |
D.N.J. |
|
|
|
|
48 |
PURDUE PHARMACEUTICAL PRODUCTS, L.P. et al |
2:12-cv-05390 |
D.N.J. |
|
|
|
|
49 |
Reckitt Benckiser Inc. v. Watson Laboratories, Inc. - Florida et al |
0:09-cv-60852 |
S.D.Fla. |
|
|
|
|
50 |
Reckitt Benckiser Inc. v. Watson Laboratories, Inc. - Florida et al |
0:09-cv-60609 |
S.D.Fla. |
|
|
|
|